KINLYTIC Trademark

Trademark Overview


On Tuesday, September 13, 2022, a trademark application was filed for KINLYTIC with the United States Patent and Trademark Office. The USPTO has given the KINLYTIC trademark a serial number of 97589684. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2024. This trademark is owned by Microbix Biosystems Inc.. The KINLYTIC trademark is filed in the Pharmaceutical Products category with the following description:

Antithrombotic drugs; thrombolytic drugs; Urokinase preparations for treating blood clots; Urokinase preparations for treating blood clots, administered intravenously; Urokinase preparations for clearing catheters and cannulas; Urokinase preparations for the restoration of patency to intravenous catheter, namely, central venous catheter, obstructed by clotted blood and fibrin; Urokinase preparations for treating pulmonary embolism; Urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; Urokinase preparations for treating thrombosis; Urokinase preparations for treating coronary artery thrombosis; Urokinase preparations for treating myocardial infarction; Urokinase preparations for the lysis of thrombi; Urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; Urokinase preparations for treating deep vein thrombosis; Urokinase preparations for treating pleural effusions; Urokinas...
kinlytic

General Information


Serial Number97589684
Word MarkKINLYTIC
Filing DateTuesday, September 13, 2022
Status700 - REGISTERED
Status DateTuesday, July 2, 2024
Registration Number7431464
Registration DateTuesday, July 2, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2024

Trademark Statements


Goods and ServicesAntithrombotic drugs; thrombolytic drugs; Urokinase preparations for treating blood clots; Urokinase preparations for treating blood clots, administered intravenously; Urokinase preparations for clearing catheters and cannulas; Urokinase preparations for the restoration of patency to intravenous catheter, namely, central venous catheter, obstructed by clotted blood and fibrin; Urokinase preparations for treating pulmonary embolism; Urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; Urokinase preparations for treating thrombosis; Urokinase preparations for treating coronary artery thrombosis; Urokinase preparations for treating myocardial infarction; Urokinase preparations for the lysis of thrombi; Urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; Urokinase preparations for treating deep vein thrombosis; Urokinase preparations for treating pleural effusions; Urokinase preparations for treating peripheral arterial occlusion; Urokinase preparations for treating ischemic stroke; Urokinase preparations for treating lower limb ischemia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMicrobix Biosystems Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMississauga L4Z1P3
CA

Party NameMicrobix Biosystems Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMississauga L4Z1P3
CA

Party NameMicrobix Biosystems Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga L4Z1P3
CA

Trademark Events


Event DateEvent Description
Wednesday, September 6, 2023NON-FINAL ACTION WRITTEN
Friday, September 16, 2022NEW APPLICATION ENTERED
Wednesday, September 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 26, 2023ASSIGNED TO EXAMINER
Wednesday, September 6, 2023NON-FINAL ACTION E-MAILED
Wednesday, September 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 16, 2024PUBLISHED FOR OPPOSITION
Saturday, March 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER